

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | microglial cell activation (GO:0001774) | 5.75767391 |
| 2 | sphingosine metabolic process (GO:0006670) | 5.51917083 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 5.21197895 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.21197895 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.21197895 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.21197895 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.21197895 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.21197895 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.16063892 |
| 10 | cellular extravasation (GO:0045123) | 5.06677183 |
| 11 | diol metabolic process (GO:0034311) | 5.06129054 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.72086738 |
| 13 | sphingoid metabolic process (GO:0046519) | 4.71841303 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.64733541 |
| 15 | respiratory burst (GO:0045730) | 4.59486216 |
| 16 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.43708786 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.39754022 |
| 18 | lipopolysaccharide metabolic process (GO:0008653) | 4.17832890 |
| 19 | macrophage activation (GO:0042116) | 4.10241512 |
| 20 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 4.08470624 |
| 21 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.99910099 |
| 22 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.98914656 |
| 23 | positive regulation of chemokine secretion (GO:0090197) | 3.92350650 |
| 24 | myeloid cell activation involved in immune response (GO:0002275) | 3.87755146 |
| 25 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.85734909 |
| 26 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.76377934 |
| 27 | mast cell degranulation (GO:0043303) | 3.68447336 |
| 28 | mast cell activation involved in immune response (GO:0002279) | 3.68447336 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 3.67185510 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 3.57963964 |
| 31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.56592518 |
| 32 | response to host immune response (GO:0052572) | 3.56592518 |
| 33 | mast cell activation (GO:0045576) | 3.49861463 |
| 34 | glycosphingolipid catabolic process (GO:0046479) | 3.43854383 |
| 35 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.42543761 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.38667179 |
| 37 | DNA methylation involved in gamete generation (GO:0043046) | 3.37742190 |
| 38 | intracellular pH reduction (GO:0051452) | 3.32759291 |
| 39 | response to host (GO:0075136) | 3.27210906 |
| 40 | response to host defenses (GO:0052200) | 3.27210906 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.27210906 |
| 42 | cell wall macromolecule catabolic process (GO:0016998) | 3.27131157 |
| 43 | positive regulation of interferon-alpha production (GO:0032727) | 3.26867800 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 3.26421468 |
| 45 | amyloid precursor protein catabolic process (GO:0042987) | 3.25728245 |
| 46 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.24573588 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 3.22548401 |
| 48 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.22548401 |
| 49 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.17935859 |
| 50 | neutrophil mediated immunity (GO:0002446) | 3.17899776 |
| 51 | L-fucose catabolic process (GO:0042355) | 3.17763587 |
| 52 | fucose catabolic process (GO:0019317) | 3.17763587 |
| 53 | L-fucose metabolic process (GO:0042354) | 3.17763587 |
| 54 | detection of molecule of bacterial origin (GO:0032490) | 3.17737720 |
| 55 | negative regulation of granulocyte differentiation (GO:0030853) | 3.16760080 |
| 56 | immunoglobulin mediated immune response (GO:0016064) | 3.12083506 |
| 57 | regulation of leukocyte degranulation (GO:0043300) | 3.11259833 |
| 58 | ceramide catabolic process (GO:0046514) | 3.09342380 |
| 59 | negative regulation of B cell apoptotic process (GO:0002903) | 3.09111047 |
| 60 | cellular response to exogenous dsRNA (GO:0071360) | 3.08531224 |
| 61 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.04071921 |
| 62 | regulation of interferon-alpha production (GO:0032647) | 3.02334018 |
| 63 | negative regulation of interleukin-6 production (GO:0032715) | 3.01926720 |
| 64 | glycolipid catabolic process (GO:0019377) | 3.00770164 |
| 65 | germinal center formation (GO:0002467) | 2.98926814 |
| 66 | regulation of gamma-delta T cell activation (GO:0046643) | 2.97404649 |
| 67 | lymphocyte chemotaxis (GO:0048247) | 2.97017468 |
| 68 | positive regulation of defense response to virus by host (GO:0002230) | 2.96418219 |
| 69 | pH reduction (GO:0045851) | 2.95625563 |
| 70 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.94027478 |
| 71 | regulation of histone phosphorylation (GO:0033127) | 2.93080517 |
| 72 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.92437101 |
| 73 | DNA deamination (GO:0045006) | 2.91650789 |
| 74 | phagosome maturation (GO:0090382) | 2.91608842 |
| 75 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.90814373 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 2.90575835 |
| 77 | negative regulation of interleukin-17 production (GO:0032700) | 2.90195689 |
| 78 | response to muramyl dipeptide (GO:0032495) | 2.89293886 |
| 79 | negative regulation of mast cell activation (GO:0033004) | 2.89238439 |
| 80 | regulation of mast cell activation (GO:0033003) | 2.88288023 |
| 81 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.87011599 |
| 82 | daunorubicin metabolic process (GO:0044597) | 2.85394213 |
| 83 | polyketide metabolic process (GO:0030638) | 2.85394213 |
| 84 | doxorubicin metabolic process (GO:0044598) | 2.85394213 |
| 85 | mannose metabolic process (GO:0006013) | 2.84629126 |
| 86 | response to xenobiotic stimulus (GO:0009410) | 2.83856193 |
| 87 | leukocyte degranulation (GO:0043299) | 2.82629128 |
| 88 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80913430 |
| 89 | positive regulation of mast cell activation (GO:0033005) | 2.80493233 |
| 90 | myeloid leukocyte activation (GO:0002274) | 2.80432118 |
| 91 | basic amino acid transport (GO:0015802) | 2.80122890 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 2.79376242 |
| 93 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.79163306 |
| 94 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.78413824 |
| 95 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.77559023 |
| 96 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.74455306 |
| 97 | regulation of regulated secretory pathway (GO:1903305) | 2.74058950 |
| 98 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.73942690 |
| 99 | T cell migration (GO:0072678) | 2.73286185 |
| 100 | negative regulation of innate immune response (GO:0045824) | 2.69700210 |
| 101 | positive regulation of histone deacetylation (GO:0031065) | 2.69272226 |
| 102 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.69166317 |
| 103 | regulation of defense response to virus by host (GO:0050691) | 2.68959654 |
| 104 | regulation of macrophage chemotaxis (GO:0010758) | 2.67096205 |
| 105 | regulation of mononuclear cell migration (GO:0071675) | 2.66391206 |
| 106 | positive regulation of B cell differentiation (GO:0045579) | 2.65557554 |
| 107 | regulation of B cell apoptotic process (GO:0002902) | 2.65073774 |
| 108 | response to peptidoglycan (GO:0032494) | 2.64599091 |
| 109 | oligosaccharide catabolic process (GO:0009313) | 2.64191578 |
| 110 | B cell receptor signaling pathway (GO:0050853) | 2.63657976 |
| 111 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.59791659 |
| 112 | deoxyribonucleotide catabolic process (GO:0009264) | 2.59625289 |
| 113 | regulation of hypersensitivity (GO:0002883) | 2.58976488 |
| 114 | RNA destabilization (GO:0050779) | 2.58757651 |
| 115 | neutrophil activation (GO:0042119) | 2.58082837 |
| 116 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.57669654 |
| 117 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.57085869 |
| 118 | negative regulation of macroautophagy (GO:0016242) | 2.57036762 |
| 119 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.56740244 |
| 120 | regulation of chemokine secretion (GO:0090196) | 2.54880827 |
| 121 | regulation of interleukin-17 production (GO:0032660) | 2.53909981 |
| 122 | negative regulation of interleukin-8 production (GO:0032717) | 2.53854502 |
| 123 | tRNA modification (GO:0006400) | 2.53525600 |
| 124 | positive regulation of acute inflammatory response (GO:0002675) | 2.53049898 |
| 125 | I-kappaB phosphorylation (GO:0007252) | 2.52355445 |
| 126 | tRNA methylation (GO:0030488) | 2.51927227 |
| 127 | purinergic receptor signaling pathway (GO:0035587) | 2.51727248 |
| 128 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.51017042 |
| 129 | positive regulation of interleukin-17 production (GO:0032740) | 2.50593828 |
| 130 | cell wall macromolecule metabolic process (GO:0044036) | 2.50028599 |
| 131 | lytic vacuole organization (GO:0080171) | 2.50005184 |
| 132 | lysosome organization (GO:0007040) | 2.50005184 |
| 133 | neutrophil chemotaxis (GO:0030593) | 2.49650672 |
| 134 | positive regulation of developmental pigmentation (GO:0048087) | 2.48434254 |
| 135 | response to thyroid hormone (GO:0097066) | 2.48433442 |
| 136 | piRNA metabolic process (GO:0034587) | 2.46466950 |
| 137 | L-amino acid import (GO:0043092) | 2.45333602 |
| 138 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.44631210 |
| 139 | granulocyte activation (GO:0036230) | 2.43767044 |
| 140 | positive regulation of macrophage cytokine production (GO:0060907) | 2.43479420 |
| 141 | low-density lipoprotein particle remodeling (GO:0034374) | 2.41718917 |
| 142 | dendritic cell chemotaxis (GO:0002407) | 2.41664501 |
| 143 | neutrophil migration (GO:1990266) | 2.40380622 |
| 144 | response to lipoprotein particle (GO:0055094) | 2.39918681 |
| 145 | hepatocyte apoptotic process (GO:0097284) | 2.39840712 |
| 146 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.39381275 |
| 147 | negative regulation of cell killing (GO:0031342) | 2.39381275 |
| 148 | hyaluronan catabolic process (GO:0030214) | 2.39067875 |
| 149 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.38466237 |
| 150 | myeloid leukocyte mediated immunity (GO:0002444) | 2.36863599 |
| 151 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.36364650 |
| 152 | regulation of cholesterol storage (GO:0010885) | 2.33911420 |
| 153 | keratan sulfate catabolic process (GO:0042340) | 2.32531246 |
| 154 | glycosylceramide metabolic process (GO:0006677) | 2.32495127 |
| 155 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.31899508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.51358681 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.95829787 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.85876692 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.58638270 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40434399 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.29355805 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.20918856 |
| 8 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.91433914 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.78295267 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.47833201 |
| 11 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46258928 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.31246696 |
| 13 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.29437166 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25181762 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.18350470 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.08141312 |
| 17 | * BCL6_27268052_Chip-Seq_Bcells_Human | 2.06215887 |
| 18 | P68_20966046_ChIP-Seq_HELA_Human | 1.98390329 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.97121658 |
| 20 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.94415943 |
| 21 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93159065 |
| 22 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.89434204 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89137006 |
| 24 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.87364444 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.87303174 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.86465099 |
| 27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.85257226 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84836413 |
| 29 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.84196472 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82624687 |
| 31 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.81844259 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.79444355 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.78246731 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.77729250 |
| 35 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.75927440 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.75754555 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75254730 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.74772719 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.74585029 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.74291518 |
| 41 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.72865641 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.72104678 |
| 43 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.65263758 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.63904534 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63781072 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63588454 |
| 47 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.59327714 |
| 48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.58435899 |
| 49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.57278414 |
| 50 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55470015 |
| 51 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.55243280 |
| 52 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55185589 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54809864 |
| 54 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.53811259 |
| 55 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53612866 |
| 56 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.53296157 |
| 57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51494878 |
| 58 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.50259175 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49609469 |
| 60 | MAF_26560356_Chip-Seq_TH1_Human | 1.48589510 |
| 61 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.47916378 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46169435 |
| 63 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44262687 |
| 64 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.43234420 |
| 65 | P300_27268052_Chip-Seq_Bcells_Human | 1.38763932 |
| 66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.37910821 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37120749 |
| 68 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36629076 |
| 69 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36526693 |
| 70 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.36343334 |
| 71 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.36046033 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35699720 |
| 73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.35476353 |
| 74 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.34934788 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33889619 |
| 76 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33422672 |
| 77 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.32470153 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31404720 |
| 79 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.31071185 |
| 80 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30752479 |
| 81 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30253571 |
| 82 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29988586 |
| 83 | * SPI1_20517297_ChIP-Seq_HL60_Human | 1.28254663 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26716949 |
| 85 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.26499716 |
| 86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25397459 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25319578 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.24082821 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23589039 |
| 90 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23245548 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22820003 |
| 92 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.22411985 |
| 93 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22128422 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22082362 |
| 95 | ERA_21632823_ChIP-Seq_H3396_Human | 1.20078211 |
| 96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19957878 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19777627 |
| 98 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.18905514 |
| 99 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18376657 |
| 100 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.18106618 |
| 101 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17796132 |
| 102 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.17241224 |
| 103 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16441938 |
| 104 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.16266098 |
| 105 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.15976864 |
| 106 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15638109 |
| 107 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15462281 |
| 108 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.15330684 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12872329 |
| 110 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12383417 |
| 111 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11488130 |
| 112 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11435056 |
| 113 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11435056 |
| 114 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.11366495 |
| 115 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.11261471 |
| 116 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11255105 |
| 117 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10690707 |
| 118 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.10679728 |
| 119 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10613606 |
| 120 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10586523 |
| 121 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10393407 |
| 122 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10195639 |
| 123 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.09253995 |
| 124 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09197501 |
| 125 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08242855 |
| 126 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.08112904 |
| 127 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.07414369 |
| 128 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06815033 |
| 129 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.06808948 |
| 130 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06179081 |
| 131 | SA1_27219007_Chip-Seq_Bcells_Human | 1.05639933 |
| 132 | MYB_26560356_Chip-Seq_TH2_Human | 1.05539614 |
| 133 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05292747 |
| 134 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05218123 |
| 135 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.04230668 |
| 136 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02262073 |
| 137 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02146256 |
| 138 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01350314 |
| 139 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00424914 |
| 140 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98886832 |
| 141 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98554684 |
| 142 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96296529 |
| 143 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.96144438 |
| 144 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95114623 |
| 145 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93977289 |
| 146 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93972898 |
| 147 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93000467 |
| 148 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91707369 |
| 149 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91657592 |
| 150 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90869354 |
| 151 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90399197 |
| 152 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.90053883 |
| 153 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.89986559 |
| 154 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88439490 |
| 155 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88216316 |
| 156 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.87735149 |
| 157 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87574906 |
| 158 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87369249 |
| 159 | AR_25329375_ChIP-Seq_VCAP_Human | 0.86105067 |
| 160 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85218596 |
| 161 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84746905 |
| 162 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84124423 |
| 163 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.83934374 |
| 164 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.83930727 |
| 165 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.83888847 |
| 166 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83623515 |
| 167 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.83589858 |
| 168 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.83413747 |
| 169 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82991023 |
| 170 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82472807 |
| 171 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82116546 |
| 172 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.82033432 |
| 173 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81503234 |
| 174 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81490076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002653_abnormal_ependyma_morphology | 4.61659172 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.26972690 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 3.93123989 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.88651365 |
| 5 | MP0006082_CNS_inflammation | 3.46588904 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.29837297 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.21009976 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.00360318 |
| 9 | MP0003646_muscle_fatigue | 2.81867757 |
| 10 | MP0003436_decreased_susceptibility_to | 2.78017120 |
| 11 | MP0003690_abnormal_glial_cell | 2.74905950 |
| 12 | MP0002419_abnormal_innate_immunity | 2.71791080 |
| 13 | MP0005171_absent_coat_pigmentation | 2.71423601 |
| 14 | MP0009840_abnormal_foam_cell | 2.57055769 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.52957336 |
| 16 | MP0009278_abnormal_bone_marrow | 2.42155515 |
| 17 | MP0003303_peritoneal_inflammation | 2.23691031 |
| 18 | MP0003724_increased_susceptibility_to | 2.17415694 |
| 19 | MP0001986_abnormal_taste_sensitivity | 2.13017061 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.01826311 |
| 21 | MP0003136_yellow_coat_color | 2.01666701 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.00966675 |
| 23 | MP0005671_abnormal_response_to | 1.96095517 |
| 24 | MP0003075_altered_response_to | 1.95750030 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.93371766 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.91724784 |
| 27 | MP0008260_abnormal_autophagy | 1.89679632 |
| 28 | MP0000604_amyloidosis | 1.87677350 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.85196245 |
| 30 | MP0005025_abnormal_response_to | 1.85122255 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.84572872 |
| 32 | MP0004381_abnormal_hair_follicle | 1.77860637 |
| 33 | MP0004510_myositis | 1.77580160 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.67062670 |
| 35 | MP0009785_altered_susceptibility_to | 1.66881090 |
| 36 | MP0001800_abnormal_humoral_immune | 1.66058534 |
| 37 | MP0002723_abnormal_immune_serum | 1.64088536 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.59682474 |
| 39 | MP0002736_abnormal_nociception_after | 1.54969001 |
| 40 | MP0010329_abnormal_lipoprotein_level | 1.53700351 |
| 41 | MP0001819_abnormal_immune_cell | 1.51009098 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.50101312 |
| 43 | MP0005085_abnormal_gallbladder_physiolo | 1.48576520 |
| 44 | MP0008004_abnormal_stomach_pH | 1.48325501 |
| 45 | MP0004859_abnormal_synaptic_plasticity | 1.47415003 |
| 46 | MP0004147_increased_porphyrin_level | 1.46982874 |
| 47 | MP0001790_abnormal_immune_system | 1.45561413 |
| 48 | MP0005387_immune_system_phenotype | 1.45561413 |
| 49 | MP0004130_abnormal_muscle_cell | 1.44251052 |
| 50 | MP0001851_eye_inflammation | 1.42704932 |
| 51 | MP0005360_urolithiasis | 1.41453914 |
| 52 | MP0005310_abnormal_salivary_gland | 1.40461798 |
| 53 | MP0002102_abnormal_ear_morphology | 1.37922530 |
| 54 | MP0000920_abnormal_myelination | 1.37166716 |
| 55 | MP0002090_abnormal_vision | 1.33886345 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32685768 |
| 57 | MP0010386_abnormal_urinary_bladder | 1.32326211 |
| 58 | MP0005166_decreased_susceptibility_to | 1.31497456 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.30293364 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.28691596 |
| 61 | MP0008469_abnormal_protein_level | 1.27785657 |
| 62 | MP0000343_altered_response_to | 1.25899343 |
| 63 | MP0003828_pulmonary_edema | 1.25832638 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.22470794 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.22470794 |
| 66 | MP0002064_seizures | 1.18682742 |
| 67 | MP0001873_stomach_inflammation | 1.16728813 |
| 68 | MP0005365_abnormal_bile_salt | 1.16624294 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.15583509 |
| 70 | MP0003633_abnormal_nervous_system | 1.15071127 |
| 71 | MP0009764_decreased_sensitivity_to | 1.12768154 |
| 72 | MP0002332_abnormal_exercise_endurance | 1.10636909 |
| 73 | MP0009763_increased_sensitivity_to | 1.10594619 |
| 74 | MP0005670_abnormal_white_adipose | 1.10335117 |
| 75 | MP0001968_abnormal_touch/_nociception | 1.08796396 |
| 76 | MP0000685_abnormal_immune_system | 1.08373873 |
| 77 | MP0002254_reproductive_system_inflammat | 1.05973512 |
| 78 | MP0005083_abnormal_biliary_tract | 1.04374308 |
| 79 | MP0001501_abnormal_sleep_pattern | 1.03976066 |
| 80 | MP0002405_respiratory_system_inflammati | 1.01995710 |
| 81 | MP0004233_abnormal_muscle_weight | 1.01563794 |
| 82 | MP0001853_heart_inflammation | 0.99551524 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.98420165 |
| 84 | MP0008874_decreased_physiological_sensi | 0.97540480 |
| 85 | MP0002822_catalepsy | 0.96727532 |
| 86 | MP0002638_abnormal_pupillary_reflex | 0.96660417 |
| 87 | MP0003011_delayed_dark_adaptation | 0.96591270 |
| 88 | MP0005451_abnormal_body_composition | 0.96097149 |
| 89 | MP0003763_abnormal_thymus_physiology | 0.95032946 |
| 90 | MP0005076_abnormal_cell_differentiation | 0.94436138 |
| 91 | MP0002998_abnormal_bone_remodeling | 0.94226757 |
| 92 | MP0000716_abnormal_immune_system | 0.94201793 |
| 93 | MP0002095_abnormal_skin_pigmentation | 0.92659530 |
| 94 | MP0005174_abnormal_tail_pigmentation | 0.91795991 |
| 95 | MP0003879_abnormal_hair_cell | 0.89506404 |
| 96 | MP0000689_abnormal_spleen_morphology | 0.88939011 |
| 97 | MP0003878_abnormal_ear_physiology | 0.88799003 |
| 98 | MP0005377_hearing/vestibular/ear_phenot | 0.88799003 |
| 99 | MP0009745_abnormal_behavioral_response | 0.88746253 |
| 100 | MP0003880_abnormal_central_pattern | 0.87852440 |
| 101 | MP0003631_nervous_system_phenotype | 0.87698112 |
| 102 | MP0003252_abnormal_bile_duct | 0.86903903 |
| 103 | * MP0002118_abnormal_lipid_homeostasis | 0.85851907 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.85704408 |
| 105 | MP0000569_abnormal_digit_pigmentation | 0.85134175 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.84294532 |
| 107 | MP0003632_abnormal_nervous_system | 0.81486775 |
| 108 | MP0002396_abnormal_hematopoietic_system | 0.81450500 |
| 109 | MP0000427_abnormal_hair_cycle | 0.80519398 |
| 110 | MP0001764_abnormal_homeostasis | 0.80214891 |
| 111 | MP0000358_abnormal_cell_content/ | 0.78820816 |
| 112 | MP0001529_abnormal_vocalization | 0.78279560 |
| 113 | MP0009333_abnormal_splenocyte_physiolog | 0.77931244 |
| 114 | MP0000609_abnormal_liver_physiology | 0.77886210 |
| 115 | MP0002398_abnormal_bone_marrow | 0.76908710 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76532064 |
| 117 | MP0003634_abnormal_glial_cell | 0.76370331 |
| 118 | MP0003329_amyloid_beta_deposits | 0.76044977 |
| 119 | MP0001502_abnormal_circadian_rhythm | 0.75597302 |
| 120 | MP0003635_abnormal_synaptic_transmissio | 0.75382448 |
| 121 | MP0000249_abnormal_blood_vessel | 0.75272060 |
| 122 | MP0002429_abnormal_blood_cell | 0.73301779 |
| 123 | MP0010155_abnormal_intestine_physiology | 0.73151408 |
| 124 | MP0002229_neurodegeneration | 0.72774558 |
| 125 | MP0000750_abnormal_muscle_regeneration | 0.72615538 |
| 126 | MP0003045_fibrosis | 0.72366790 |
| 127 | MP0004883_abnormal_blood_vessel | 0.71396093 |
| 128 | MP0004133_heterotaxia | 0.70883713 |
| 129 | MP0009046_muscle_twitch | 0.70487876 |
| 130 | MP0004947_skin_inflammation | 0.70002164 |
| 131 | MP0005319_abnormal_enzyme/_coenzyme | 0.69618962 |
| 132 | MP0002075_abnormal_coat/hair_pigmentati | 0.69084879 |
| 133 | MP0006035_abnormal_mitochondrial_morpho | 0.66949169 |
| 134 | MP0002722_abnormal_immune_system | 0.65558901 |
| 135 | MP0001663_abnormal_digestive_system | 0.65361365 |
| 136 | MP0002572_abnormal_emotion/affect_behav | 0.65175895 |
| 137 | MP0005535_abnormal_body_temperature | 0.64883340 |
| 138 | MP0003806_abnormal_nucleotide_metabolis | 0.63191027 |
| 139 | MP0006054_spinal_hemorrhage | 0.61583651 |
| 140 | MP0000703_abnormal_thymus_morphology | 0.58687817 |
| 141 | MP0001486_abnormal_startle_reflex | 0.56736096 |
| 142 | MP0000371_diluted_coat_color | 0.55073562 |
| 143 | MP0002168_other_aberrant_phenotype | 0.54892686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 6.57527570 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 6.57060898 |
| 3 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 6.02170207 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.74930636 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.74930636 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.74930636 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.42236398 |
| 8 | Glomerulonephritis (HP:0000099) | 5.33385619 |
| 9 | Recurrent abscess formation (HP:0002722) | 5.06359675 |
| 10 | Complement deficiency (HP:0004431) | 4.79369079 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.63185484 |
| 12 | Dysostosis multiplex (HP:0000943) | 4.56399520 |
| 13 | Agnosia (HP:0010524) | 4.27021586 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.27002185 |
| 15 | Abnormality of complement system (HP:0005339) | 3.87748457 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.85858934 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.85858934 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.85858934 |
| 19 | Prostate neoplasm (HP:0100787) | 3.79367529 |
| 20 | Mucopolysacchariduria (HP:0008155) | 3.77281591 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.77281591 |
| 22 | Amelogenesis imperfecta (HP:0000705) | 3.66619621 |
| 23 | Eczematoid dermatitis (HP:0000976) | 3.53552097 |
| 24 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.53338697 |
| 25 | Axonal loss (HP:0003447) | 3.44542472 |
| 26 | Retinal atrophy (HP:0001105) | 3.15798891 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 3.11185336 |
| 28 | Abnormality of macrophages (HP:0004311) | 3.05100844 |
| 29 | Recurrent skin infections (HP:0001581) | 2.95721825 |
| 30 | Albinism (HP:0001022) | 2.92950816 |
| 31 | Nephritis (HP:0000123) | 2.88947161 |
| 32 | Joint hemorrhage (HP:0005261) | 2.87475848 |
| 33 | Upper motor neuron abnormality (HP:0002127) | 2.80253516 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73644693 |
| 35 | Agammaglobulinemia (HP:0004432) | 2.72213583 |
| 36 | Loss of speech (HP:0002371) | 2.69687571 |
| 37 | Stomatitis (HP:0010280) | 2.69051990 |
| 38 | Congenital stationary night blindness (HP:0007642) | 2.67758592 |
| 39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.66966998 |
| 40 | Myositis (HP:0100614) | 2.65360059 |
| 41 | Amyloidosis (HP:0011034) | 2.60336093 |
| 42 | Hepatosplenomegaly (HP:0001433) | 2.59802896 |
| 43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.57236034 |
| 44 | Petechiae (HP:0000967) | 2.54132792 |
| 45 | Myocardial infarction (HP:0001658) | 2.48520823 |
| 46 | Disinhibition (HP:0000734) | 2.47659489 |
| 47 | Abnormality of the prostate (HP:0008775) | 2.47584721 |
| 48 | Focal motor seizures (HP:0011153) | 2.40689296 |
| 49 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.39744017 |
| 50 | Gingivitis (HP:0000230) | 2.39223764 |
| 51 | Pustule (HP:0200039) | 2.38911115 |
| 52 | Parakeratosis (HP:0001036) | 2.36904366 |
| 53 | Molar tooth sign on MRI (HP:0002419) | 2.36562954 |
| 54 | Abnormality of midbrain morphology (HP:0002418) | 2.36562954 |
| 55 | Neuronal loss in central nervous system (HP:0002529) | 2.35437012 |
| 56 | Progressive neurologic deterioration (HP:0002344) | 2.33918800 |
| 57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31558413 |
| 58 | Obstructive lung disease (HP:0006536) | 2.31558413 |
| 59 | Progressive visual loss (HP:0000529) | 2.30100874 |
| 60 | Arterial tortuosity (HP:0005116) | 2.28156000 |
| 61 | Deformed sella turcica (HP:0002681) | 2.27030366 |
| 62 | Mutism (HP:0002300) | 2.26873879 |
| 63 | Severe combined immunodeficiency (HP:0004430) | 2.25636487 |
| 64 | Neurofibrillary tangles (HP:0002185) | 2.24327532 |
| 65 | Microvesicular hepatic steatosis (HP:0001414) | 2.24118309 |
| 66 | Orchitis (HP:0100796) | 2.23983178 |
| 67 | J-shaped sella turcica (HP:0002680) | 2.22014872 |
| 68 | Global brain atrophy (HP:0002283) | 2.20087988 |
| 69 | Anterior segment dysgenesis (HP:0007700) | 2.18509622 |
| 70 | Severe visual impairment (HP:0001141) | 2.17686391 |
| 71 | Thrombocytosis (HP:0001894) | 2.16086558 |
| 72 | Granulocytopenia (HP:0001913) | 2.15945714 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.14113126 |
| 74 | Mediastinal lymphadenopathy (HP:0100721) | 2.13981210 |
| 75 | Abnormality of B cell number (HP:0010975) | 2.12110851 |
| 76 | Gastrointestinal stroma tumor (HP:0100723) | 2.10465836 |
| 77 | Periodontitis (HP:0000704) | 2.08894459 |
| 78 | Thoracic kyphosis (HP:0002942) | 2.06751895 |
| 79 | Partial agenesis of the corpus callosum (HP:0001338) | 2.05091472 |
| 80 | Retrobulbar optic neuritis (HP:0100654) | 2.02114517 |
| 81 | Optic neuritis (HP:0100653) | 2.02114517 |
| 82 | Hemoptysis (HP:0002105) | 2.01675527 |
| 83 | Basal ganglia calcification (HP:0002135) | 2.01518513 |
| 84 | Prolonged bleeding time (HP:0003010) | 1.99933788 |
| 85 | Progressive microcephaly (HP:0000253) | 1.99388816 |
| 86 | Autoimmune thrombocytopenia (HP:0001973) | 1.99044665 |
| 87 | Asymmetric septal hypertrophy (HP:0001670) | 1.98115486 |
| 88 | Pancreatic cysts (HP:0001737) | 1.97996269 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 1.97689388 |
| 90 | Epistaxis (HP:0000421) | 1.97398230 |
| 91 | Hypoplasia of the thymus (HP:0000778) | 1.97057537 |
| 92 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.96081099 |
| 93 | Leukocytosis (HP:0001974) | 1.95587349 |
| 94 | Hypercholesterolemia (HP:0003124) | 1.95138035 |
| 95 | Xanthomatosis (HP:0000991) | 1.94560994 |
| 96 | Sepsis (HP:0100806) | 1.94382319 |
| 97 | Visual hallucinations (HP:0002367) | 1.92707644 |
| 98 | Cerebellar dysplasia (HP:0007033) | 1.91798105 |
| 99 | Hyperlipoproteinemia (HP:0010980) | 1.91409787 |
| 100 | Spastic tetraparesis (HP:0001285) | 1.90782153 |
| 101 | Nephronophthisis (HP:0000090) | 1.90672750 |
| 102 | Vasculitis (HP:0002633) | 1.90188042 |
| 103 | Pathologic fracture (HP:0002756) | 1.90062318 |
| 104 | Cellulitis (HP:0100658) | 1.89631986 |
| 105 | Peripheral demyelination (HP:0011096) | 1.89573332 |
| 106 | Clumsiness (HP:0002312) | 1.88224086 |
| 107 | Lissencephaly (HP:0001339) | 1.88153300 |
| 108 | Abnormality of eosinophils (HP:0001879) | 1.88084323 |
| 109 | Deep venous thrombosis (HP:0002625) | 1.88054979 |
| 110 | Increased serum ferritin (HP:0003281) | 1.87200542 |
| 111 | Progressive inability to walk (HP:0002505) | 1.86532804 |
| 112 | Vascular tortuosity (HP:0004948) | 1.86405541 |
| 113 | Difficulty walking (HP:0002355) | 1.86340582 |
| 114 | Lower limb hyperreflexia (HP:0002395) | 1.85976223 |
| 115 | Recurrent viral infections (HP:0004429) | 1.85958609 |
| 116 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85939672 |
| 117 | Prolonged partial thromboplastin time (HP:0003645) | 1.84736225 |
| 118 | Chest pain (HP:0100749) | 1.84645625 |
| 119 | Inability to walk (HP:0002540) | 1.84249758 |
| 120 | Chronic diarrhea (HP:0002028) | 1.84056197 |
| 121 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.83893325 |
| 122 | Recurrent cutaneous fungal infections (HP:0011370) | 1.83893325 |
| 123 | Retinal dysplasia (HP:0007973) | 1.83756316 |
| 124 | Colitis (HP:0002583) | 1.83492050 |
| 125 | Opisthotonus (HP:0002179) | 1.83264174 |
| 126 | Abnormality of the periventricular white matter (HP:0002518) | 1.82113010 |
| 127 | Chronic hepatic failure (HP:0100626) | 1.80126938 |
| 128 | B lymphocytopenia (HP:0010976) | 1.79015199 |
| 129 | Cheilitis (HP:0100825) | 1.78343601 |
| 130 | Pendular nystagmus (HP:0012043) | 1.78155714 |
| 131 | Osteomyelitis (HP:0002754) | 1.76815733 |
| 132 | Hematochezia (HP:0002573) | 1.76814275 |
| 133 | Eosinophilia (HP:0001880) | 1.76805052 |
| 134 | Pulmonary infiltrates (HP:0002113) | 1.76570685 |
| 135 | Combined immunodeficiency (HP:0005387) | 1.75847319 |
| 136 | Meningitis (HP:0001287) | 1.75512213 |
| 137 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.75320558 |
| 138 | Inflammation of the large intestine (HP:0002037) | 1.74373567 |
| 139 | Type II lissencephaly (HP:0007260) | 1.74335278 |
| 140 | Hypoplasia of the brainstem (HP:0002365) | 1.73268386 |
| 141 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.73268386 |
| 142 | Abnormality of iron homeostasis (HP:0011031) | 1.71904830 |
| 143 | Gingival bleeding (HP:0000225) | 1.71758545 |
| 144 | Polyphagia (HP:0002591) | 1.71488992 |
| 145 | Impaired platelet aggregation (HP:0003540) | 1.71213607 |
| 146 | Abnormal platelet function (HP:0011869) | 1.71213607 |
| 147 | Inappropriate behavior (HP:0000719) | 1.71147472 |
| 148 | Recurrent fungal infections (HP:0002841) | 1.70988140 |
| 149 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.70851465 |
| 150 | Keratoconjunctivitis sicca (HP:0001097) | 1.69255566 |
| 151 | Bundle branch block (HP:0011710) | 1.68276070 |
| 152 | Dementia (HP:0000726) | 1.67775350 |
| 153 | Cardiomegaly (HP:0001640) | 1.67656102 |
| 154 | Urticaria (HP:0001025) | 1.67114534 |
| 155 | Sensorimotor neuropathy (HP:0007141) | 1.66051235 |
| 156 | Failure to thrive in infancy (HP:0001531) | 1.65601019 |
| 157 | Urethral obstruction (HP:0000796) | 1.65099390 |
| 158 | Spondylolisthesis (HP:0003302) | 1.64777640 |
| 159 | Abolished electroretinogram (ERG) (HP:0000550) | 1.64635583 |
| 160 | Myoclonus (HP:0001336) | 1.63964719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 5.45417678 |
| 2 | RIPK4 | 4.13881914 |
| 3 | TGFBR2 | 3.62399627 |
| 4 | MAPK15 | 3.51278509 |
| 5 | TESK2 | 3.35891252 |
| 6 | KIT | 3.01609282 |
| 7 | MAP3K14 | 2.93261177 |
| 8 | BLK | 2.92912573 |
| 9 | CSF1R | 2.44087291 |
| 10 | LATS1 | 2.16181780 |
| 11 | GRK7 | 2.09877267 |
| 12 | PRKD2 | 2.08802522 |
| 13 | MAP3K13 | 2.05584377 |
| 14 | ZAK | 2.04979590 |
| 15 | TYK2 | 2.03915060 |
| 16 | IRAK4 | 2.01221724 |
| 17 | CASK | 1.98907938 |
| 18 | MAP3K11 | 1.95393206 |
| 19 | PRKD3 | 1.82875589 |
| 20 | PRPF4B | 1.80722622 |
| 21 | GRK6 | 1.72680377 |
| 22 | MAP2K2 | 1.67458320 |
| 23 | PIM2 | 1.60551032 |
| 24 | IRAK3 | 1.57625296 |
| 25 | MAP4K1 | 1.52831195 |
| 26 | BCKDK | 1.49949478 |
| 27 | TAOK3 | 1.48001295 |
| 28 | CDK9 | 1.47890966 |
| 29 | MAP4K2 | 1.44152307 |
| 30 | TNK2 | 1.43955468 |
| 31 | CLK1 | 1.43621917 |
| 32 | FES | 1.41527612 |
| 33 | BMPR2 | 1.38944529 |
| 34 | JAK1 | 1.37249293 |
| 35 | NEK9 | 1.36213601 |
| 36 | CAMKK2 | 1.34259751 |
| 37 | MATK | 1.31930014 |
| 38 | VRK2 | 1.29395621 |
| 39 | MARK3 | 1.29207294 |
| 40 | MAP3K6 | 1.25969072 |
| 41 | TBK1 | 1.24279725 |
| 42 | MARK2 | 1.23838693 |
| 43 | MAP2K3 | 1.20651181 |
| 44 | MAP3K12 | 1.17431180 |
| 45 | SYK | 1.17276287 |
| 46 | FGR | 1.13394090 |
| 47 | PAK6 | 1.13026553 |
| 48 | SGK2 | 1.11885179 |
| 49 | HCK | 1.06633942 |
| 50 | MAP2K7 | 1.06387224 |
| 51 | STK38 | 1.05084011 |
| 52 | TAOK1 | 1.04878425 |
| 53 | ERN1 | 1.04544704 |
| 54 | DAPK2 | 1.03282201 |
| 55 | SIK3 | 1.01632499 |
| 56 | SIK2 | 0.99952069 |
| 57 | EPHA4 | 0.98612405 |
| 58 | TXK | 0.97930063 |
| 59 | SMG1 | 0.97315322 |
| 60 | TLK1 | 0.96708011 |
| 61 | KSR2 | 0.94705344 |
| 62 | ZAP70 | 0.93117617 |
| 63 | JAK3 | 0.92390189 |
| 64 | NTRK3 | 0.91970585 |
| 65 | STK38L | 0.91890178 |
| 66 | LYN | 0.89998031 |
| 67 | CAMK1D | 0.89454937 |
| 68 | MAPK12 | 0.88540307 |
| 69 | STK11 | 0.87783188 |
| 70 | CSNK1A1L | 0.87565265 |
| 71 | MAP2K4 | 0.87489759 |
| 72 | SGK3 | 0.85370129 |
| 73 | LCK | 0.84347132 |
| 74 | MOS | 0.84343755 |
| 75 | PINK1 | 0.83692888 |
| 76 | CAMKK1 | 0.83248308 |
| 77 | FLT3 | 0.83121542 |
| 78 | JAK2 | 0.81169287 |
| 79 | FRK | 0.80466042 |
| 80 | IKBKB | 0.80299739 |
| 81 | CCNB1 | 0.79113970 |
| 82 | TEC | 0.77757996 |
| 83 | TRPM7 | 0.76749312 |
| 84 | SGK223 | 0.75559738 |
| 85 | SGK494 | 0.75559738 |
| 86 | LATS2 | 0.75479407 |
| 87 | ICK | 0.74778925 |
| 88 | ADRBK2 | 0.74578290 |
| 89 | BTK | 0.73407445 |
| 90 | CSK | 0.72307746 |
| 91 | PRKCH | 0.70872964 |
| 92 | MAPK13 | 0.69858561 |
| 93 | BRAF | 0.69773274 |
| 94 | RAF1 | 0.69652381 |
| 95 | PLK2 | 0.68622332 |
| 96 | MAPK7 | 0.67370024 |
| 97 | ITK | 0.67214413 |
| 98 | PRKCI | 0.67185229 |
| 99 | PIK3CA | 0.66493634 |
| 100 | MAPKAPK5 | 0.66250833 |
| 101 | TNIK | 0.63533059 |
| 102 | ADRBK1 | 0.63230385 |
| 103 | MAP3K7 | 0.63152050 |
| 104 | EPHA3 | 0.62732719 |
| 105 | PRKD1 | 0.61434963 |
| 106 | INSRR | 0.61407272 |
| 107 | MAP2K6 | 0.60826419 |
| 108 | CAMK1G | 0.60143670 |
| 109 | MELK | 0.59126785 |
| 110 | GRK5 | 0.55905730 |
| 111 | RPS6KA6 | 0.52513710 |
| 112 | PDK1 | 0.50773800 |
| 113 | PTK2B | 0.50679328 |
| 114 | CDK3 | 0.50358631 |
| 115 | CDK19 | 0.50067411 |
| 116 | IKBKE | 0.49904333 |
| 117 | MAP3K4 | 0.49753910 |
| 118 | CDK8 | 0.49702512 |
| 119 | MAP3K3 | 0.49670847 |
| 120 | AKT3 | 0.49660954 |
| 121 | YES1 | 0.48893026 |
| 122 | PIM1 | 0.48863879 |
| 123 | KDR | 0.48421368 |
| 124 | VRK1 | 0.48284357 |
| 125 | PDPK1 | 0.47931463 |
| 126 | CHUK | 0.46854042 |
| 127 | ACVR1B | 0.45481972 |
| 128 | PRKAA2 | 0.45099373 |
| 129 | IGF1R | 0.44742255 |
| 130 | GRK1 | 0.44169349 |
| 131 | PRKCQ | 0.44025020 |
| 132 | DAPK1 | 0.43767346 |
| 133 | MAP3K9 | 0.42854358 |
| 134 | MAP3K1 | 0.42499829 |
| 135 | ABL2 | 0.41452194 |
| 136 | MUSK | 0.41124634 |
| 137 | SIK1 | 0.39299726 |
| 138 | CAMK4 | 0.39197311 |
| 139 | PRKG1 | 0.37895065 |
| 140 | RPS6KA2 | 0.37880529 |
| 141 | EIF2AK2 | 0.36152367 |
| 142 | NUAK1 | 0.35558596 |
| 143 | EPHB1 | 0.34910795 |
| 144 | MAPK4 | 0.34198758 |
| 145 | PRKCD | 0.32998926 |
| 146 | PKN1 | 0.32765837 |
| 147 | ARAF | 0.32557488 |
| 148 | NTRK2 | 0.32201786 |
| 149 | STK10 | 0.31350259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.22544846 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.82389756 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.81003347 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 3.40151283 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.63917663 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.42183609 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.41114249 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.14550777 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07433128 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 1.94428322 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82392009 |
| 12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.75155267 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.72536597 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.69955518 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 1.68027315 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.67921968 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61103698 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.60882177 |
| 19 | Phototransduction_Homo sapiens_hsa04744 | 1.59220708 |
| 20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.58834461 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.56047411 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.55420167 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55222117 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.51881451 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.42246274 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38449409 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38089657 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.34273138 |
| 29 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.31715982 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22787967 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21793329 |
| 32 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.21687653 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17465811 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.14765148 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.13305409 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.09929132 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06671283 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.06471140 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.04295751 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.03374001 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01452325 |
| 42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00142154 |
| 43 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98704095 |
| 44 | Malaria_Homo sapiens_hsa05144 | 0.96232553 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95154756 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.95006331 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94762414 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.93909414 |
| 49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.91770360 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 0.91439264 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.91344009 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90146697 |
| 53 | Nicotine addiction_Homo sapiens_hsa05033 | 0.85360527 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83482393 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81444406 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81435940 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.80642170 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80347629 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79955631 |
| 60 | Morphine addiction_Homo sapiens_hsa05032 | 0.78929321 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78923742 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78670584 |
| 63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.77947536 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76766949 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75444304 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74143218 |
| 67 | Taste transduction_Homo sapiens_hsa04742 | 0.73669926 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72971248 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72752775 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.72517114 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.72385563 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70939620 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.68467362 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68465952 |
| 75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68013312 |
| 76 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66377824 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66377494 |
| 78 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.66217149 |
| 79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64990164 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.63643232 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62670353 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62228124 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62088811 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.61191805 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60961837 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60492866 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.60411135 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60091000 |
| 89 | Influenza A_Homo sapiens_hsa05164 | 0.59973672 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.57848835 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57667359 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57377584 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56972047 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56857683 |
| 95 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.56669469 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56502997 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55604514 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55147477 |
| 99 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.54443103 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54306409 |
| 101 | Circadian entrainment_Homo sapiens_hsa04713 | 0.54241679 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54155579 |
| 103 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.53940506 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53207148 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52538323 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52363531 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52224496 |
| 108 | Base excision repair_Homo sapiens_hsa03410 | 0.51925539 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.51502524 |
| 110 | Measles_Homo sapiens_hsa05162 | 0.51355234 |
| 111 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50287052 |
| 112 | Hepatitis B_Homo sapiens_hsa05161 | 0.50235536 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50134543 |
| 114 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48202470 |
| 115 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48199937 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47618285 |
| 117 | Salivary secretion_Homo sapiens_hsa04970 | 0.47156883 |
| 118 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46760031 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46375525 |
| 120 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45794048 |
| 121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.44767860 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.44361209 |
| 123 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.44309020 |
| 124 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42023788 |
| 125 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41767033 |
| 126 | Lysine degradation_Homo sapiens_hsa00310 | 0.41267164 |
| 127 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39904543 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39852846 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39748169 |
| 130 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39072548 |
| 131 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38982795 |
| 132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38863758 |
| 133 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38825291 |
| 134 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37616986 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.36972082 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36734189 |
| 137 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.36294975 |
| 138 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.35759576 |
| 139 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34623145 |
| 140 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33496611 |
| 141 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33261477 |
| 142 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.32950130 |
| 143 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32618178 |
| 144 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.31738709 |
| 145 | Amoebiasis_Homo sapiens_hsa05146 | 0.30949719 |

